Sleep Loss and Circadian Misalignment - Mechanisms of Insulin Resistance

Trial statusNot yet recruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18-45
SponsorWashington State University

About this trial

The purpose of this study is to examine the impact of timed cortisol release or differently timed cortisol rhythms on insulin resistance in both men and women undergoing sleep restriction. Chronic sleep loss is highly prevalent, affecting 1 in 3 adults in the US. Chronic sleep loss causes stress which induces insulin resistance and leads to obesity and type 2 diabetes. Many factors contribute to sleep loss including shift work, environmental disturbances, sleep/circadian disorders and comorbid medical and mental health conditions. Sleep loss increases the stress hormone cortisol in the evening and decreases daytime testosterone. Examining these hormones in a controlled laboratory environment under different sleep schedules may help researchers find solutions for adults experiencing negative health consequences related to chronic sleep loss.

Eligibility criteria

Qualifiers

Must be between 18-45 years old.

Has a BMI of 18-25 kg/m2 stable weight over the previous 6 weeks.

Is physically and psychologically healthy (incl. regular menstrual cycles in women, no clinical disorders and/or illnesses). Women will be studied during the follicular phase of their menstrual cycle.

No current medical or drug treatment (to include steroids or hormones of any type including contraceptives), as assessed by questionnaire.

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Metyrapone And Hydrocortisone
  • Dextrose
  • insulin

Treatment groups

48 Participants
are divided into 4 treatment groups

Sponsors and collaborators

Washington State University

Lead sponsor

Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

Collaborator